A simple blood draw may eventually help doctors estimate whether an apparently healthy older adult is likely to experience cognitive decline years before memory problems become noticeable.
New research involving nearly 2,700 cognitively healthy adults found that elevated levels of a blood biomarker known as phosphorylated tau 217, or p-tau217, were associated with a substantially greater risk of developing cognitive impairment over the following five to 10 years.
The findings represent an important step toward identifying Alzheimer’s disease during its “silent” stage, when damaging changes may already be developing in the brain but the person continues to think, remember and function normally.
Researchers believe that earlier identification could eventually allow doctors to intervene before extensive brain damage occurs. For now, however, experts caution that the test…




